Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
A 69-Year-Old Man With Advanced Castrate-Resistant Prostate Cancer
Jorge Garcia, MD, FACP, provides insight on the case of a 69-year-old man with mCRPC and assesses the classes of agents currently available as treatment options.
A 68-Year-Old Man With Mantle Cell Lymphoma
Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.
A 68-Year-Old Woman with Metastatic NTRK Fusion-Positive Colon Cancer
Cathy Eng, MD, FACP, FASCO, reviews the case of a 68-year-old diagnosed with metastatic NTRK fusion-positive colon cancer and shares treatments options.
A 61-Year-Old Man With Acute Graft-Versus-Host Disease
Usama Gergis, MD, presents the case of a 61-year old man with GvHD, and provides an overview of available treatment options for similar patients, with consideration of the REACH1, REACH2, and GRAVITAS-301 trial regimens.
A 67-Year-Old Man With NTRK Fusion-Positive Metastatic Lung Cancer
Luis Raez, MD, reviews the case of a 67-year-old man with metastatic non-small cell NTRK gene fusion lung cancer.
A 59-Year-Old Woman With HER2+ De Novo Metastatic Breast Cancer
A 59-Year Old Woman With Stage IIIC Ovarian Cancer
A 69-Year Old Man With Metastatic BRAF V600E-Mutated Metastatic NSCLC
A 54-Year-Old Woman With Stage 2 HER2+ Breast Cancer
A 62-Year-Old Woman With Metastatic BRAF V600E-Mutated NSCLC
A 63-Year-Old Woman With Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
A 75-Year-Old Man With Metastatic Castrate-Resistant Prostate Cancer
A 60-Year Old Man With Untreated Stage IV EGFR-Mutated Non-Small Cell Lung Cancer
A 72-Year-Old Man With Symptomatic Follicular Lymphoma
A 62-Year-Old Male With Stage III Non-Small Cell Lung Cancer
A 64-Year-Old Male with Untreated Stage IV EGFR-Mutated NSCLC
A 56-Year-Old Female With Recurrent Ovarian Cancer
TKI in Poor-Risk Advanced Renal Cell Carcinoma
Managing A Case of Heavily Pretreated Recurrent Ovarian Cancer
Rapidly Progressing Acute Myeloid Leukemia
Frontline TKI in Intermediate-Risk Renal Cell Carcinoma
First-Line PARPi Maintenance in Advanced Ovarian Cancer
Transplant-Eligible Newly Diagnosed Multiple Myeloma
Outcomes in Newly Diagnosed Transplant-Ineligible Multiple Myeloma
Improving Overall Survival In Extensive Stage Small Cell Lung Cancer
Follicular Lymphoma: Treating Early Progressors
A 59-Year-Old Man With Relapsed Follicular Lymphoma
Refractory Hepatocellular Carcinoma
Relapsed ALK-Rearranged NSCLC
Optimal Management of Relapsed/Refractory mHCC
2 Clarke Drive Cranbury, NJ 08512